Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • pharma news india

    Tag: pharma news india

    You Searched For "pharma news india"
    Lupin unveils generic version of Prozac tablets in US

    Lupin unveils generic version of Prozac tablets in US

    Medical Dialogues Bureau24 Aug 2019 9:45 AM IST
    Fluoxetine tablet is a generic version of Eli Lilly and Company's Prozac tablets in the same strengths, Lupin said.Mumba: Pharma major Lupin Limited...
    Rationalisation of 294 FDC drugs: CDSCO issues Fresh directions to manufacturers

    Rationalisation of 294 FDC drugs: CDSCO issues Fresh directions to manufacturers

    Medical Dialogues Bureau23 Aug 2019 12:27 PM IST
    New Delhi: In a move to regularise Fixed Dose Combinations (FDCs), the Central Drugs Standard Control Organization (CDSCO) has notified the process to...
    Granules India gets 2 USFDA observations for Chantilly facility

    Granules India gets 2 USFDA observations for Chantilly facility

    Medical Dialogues Bureau23 Aug 2019 11:46 AM IST
    "The United States Food and Drug Administration (USFDA) has completed inspection of the facility of Granules Pharmaceuticals Inc, a wholly-owned...
    Dr Reddys gets 8 USFDA observations for Duvvada facility in Andhra Pradesh

    Dr Reddys gets 8 USFDA observations for Duvvada facility in Andhra Pradesh

    Medical Dialogues Bureau21 Aug 2019 10:00 AM IST
    The audit of Dr Reddy's formulations manufacturing plant (Vizag SEZ Plant 1) at Duvvada, Visakhapatnam by the United States Food and Drug...
    Lupin gets USFDA approval for generic version of Westcort cream to treat skin conditions

    Lupin gets USFDA approval for generic version of Westcort cream to treat skin conditions

    Farhat Nasim18 Aug 2019 9:46 AM IST
    Hydrocortisone Valerate cream is a generic version of Sun Pharmaceutical Industries Ltd's Westcort cream in the same strength, Lupin added.New Delhi:...
    Lupin gets USFDA nod for generic version of Prozac tablets to treat depressive disorder

    Lupin gets USFDA nod for generic version of Prozac tablets to treat depressive disorder

    Medical Dialogues Bureau17 Aug 2019 9:45 AM IST
    The company has received approval for Fluoxetine Tablets from the US Food and Drug Administration(USFDA) to market its product which is a generic...
    NPPA fixes retail price of 10 combo drugs including Metformin, Rosuvastatin; Details

    NPPA fixes retail price of 10 combo drugs including Metformin, Rosuvastatin; Details

    Farhat Nasim16 Aug 2019 4:01 PM IST
    New Delhi: Through a recent notification, the apex drug price regulatory agency, the National Pharmaceutical Pricing Authority (NPPA) has fixed the...
    Emcure Pharma gets USFDA Warning Letter for Manufacturing Violations at Pune plant

    Emcure Pharma gets USFDA Warning Letter for Manufacturing Violations at Pune plant

    Medical Dialogues Bureau16 Aug 2019 9:45 AM IST
    In the letter, the USFDA said inspectors during February 11-20 this year found significant deviations from standard manufacturing practices at Emcure...
    Sun Pharma records Total Revenue of Rs 8374.36 crore for June quarter

    Sun Pharma records Total Revenue of Rs 8374.36 crore for June quarter

    Medical Dialogues Bureau16 Aug 2019 9:30 AM IST
    Mumbai: India's largest drugmaker Sun Pharmaceutical Industries Ltd. (Sun Pharma) recently reported a consolidated net profit of Rs 1,387.48 crore...
    Natco Pharma gets 6 USFDA observations for API facility near Hyderabad

    Natco Pharma gets 6 USFDA observations for API facility near Hyderabad

    Medical Dialogues Bureau13 Aug 2019 1:16 PM IST
    Natco Pharma said it will provide due justifications and corrective action plan within the next 15 working days to address the USFDA observations.NEW...
    Indoco Remedies successfully completes USFDA inspection of CRO Anacipher in Hyderabad

    Indoco Remedies successfully completes USFDA inspection of CRO Anacipher in Hyderabad

    Medical Dialogues Bureau13 Aug 2019 9:45 AM IST
    "This is the fourth successive USFDA inspection with ZERO 483 for our CRO – AnaCipher," stated Ms Aditi Kare Panandikar, Managing Director, Indoco...
    Zydus Cadila total income up by 21 percent to Rs 3496 crore in Q1

    Zydus Cadila total income up by 21 percent to Rs 3496 crore in Q1

    Medical Dialogues Bureau10 Aug 2019 12:43 PM IST
    During the quarter, Zydus Cadila entered into a marketing alliance with SIFI, the Italian leader in the development of therapeutic solutions for...
    PrevNext

    Popular Stories

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok